Long-Term Consequences of Severe Maternal Morbidity on Infant Growth and Development

Dulce M Zanardi1, Juliana P Santos1, Rodolfo C Pacagnella1

  • 1Department of Obstetrics and Gynecology, School of Medical Sciences, CAISM, University of Campinas, Campinas, Brazil.

Insights

Severe maternal morbidity (SMM) negatively impacts child growth and neurodevelopment. Addressing maternal health through effective policies can reduce infant and neonatal complications.

Area of Science:

  • Obstetrics and Gynecology
  • Pediatrics
  • Public Health

Background:

  • Severe maternal morbidity (SMM) is linked to adverse neonatal outcomes.
  • Long-term effects of SMM on child growth and neurodevelopment require further assessment.

Purpose of the Study:

  • To evaluate the repercussions of SMM on child weight-for-age, height-for-age, and neurodevelopmental status.
  • To assess the association between SMM and long-term child health deficits.

Main Methods:

  • Retrospective cohort analysis of women with and without SMM events in a Brazilian tertiary referral center.
  • Comparative assessment of childbirth, perinatal characteristics, growth deficits, and neurodevelopmental status using RR and 95% CI.
  • Multiple regression analysis to determine independent adjusted RR for weight-for-age, height-for-age, and neurodevelopmental outcomes.

Main Results:

  • Women with SMM experienced higher rates of preterm birth, low birthweight, and deficits in weight-for-age and height-for-age.
  • Increased suspicion of neurodevelopmental impairment (altered Denver Test) was observed in children exposed to SMM.
  • Despite observed associations, SMM was not independently linked to the main outcomes in regression analysis.

Conclusions:

  • Severe maternal morbidity is associated with negative impacts on perinatal and infant growth and neurodevelopment.
  • Findings underscore the importance of effective maternal healthcare policies for reducing maternal, neonatal, and infant morbidity and mortality.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.6K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
600